{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:48:11Z","timestamp":1776876491356,"version":"3.51.2"},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:00:00Z","timestamp":1519257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["877\/10"],"award-info":[{"award-number":["877\/10"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although autoimmune diseases (AIDs) are known to predispose to non\u2010Hodgkin lymphoma (NHL), their association with NHL prognosis has rarely been investigated. We examined associations between autoimmunity and B\u2010cell NHL onset by comparing AID history (determined by self\u2010report and medication review and supplemented by chart review where possible) among 435 adult B\u2010NHL patients in Hadassah\u2010Hebrew University Medical Center, diagnosed 2009\u20102014, and 414 age\u2010and\u2010sex frequency\u2010matched controls. We examined AIDs as a whole, B\u2010 and T\u2010cell\u2013mediated AIDs, and autoimmune thyroid diseases. Among cases, we used Kaplan\u2010Meier and Cox regression models to assess the association of AID with overall survival and relapse\u2010free survival, adjusting for prognostically important patient and disease characteristics such as Ki67% staining, International Prognostic Index, rituximab treatment, and histological subgroup.<\/jats:p><jats:p>Autoimmune diseases were associated with B\u2010NHL (odds ratio [OR]\u00a0=\u00a01.95; 95% confidence interval (CI), 1.31\u20102.92), especially AIDs mediated by B\u2010cell activation (OR\u00a0=\u00a05.20; CI, 1.90\u201014.3), which were particularly associated with marginal zone lymphoma (OR\u00a0=\u00a019.3; CI, 4.59\u201080.9). We found that time to relapse for all B\u2010NHL patients with AIDs was significantly shorter (mean of 49.21\u00a0mo [\u00b13.22]) than among patients without AID (mean of 59.74\u00a0mo [\u00b11.62]), adjusted hazard ratio [HR<jats:sub>adj<\/jats:sub>]\u00a0=\u00a01.69 (CI, 1.03\u20102.79). Specifically, in patients with diffuse large B\u2010cell lymphoma, of whom 91.8% had received rituximab, a history of B\u2010cell\u2013mediated AIDs was associated with shorter relapse\u2010free survival and overall survival, HR<jats:sub>adj<\/jats:sub>\u00a0=\u00a08.34 (CI, 3.01\u201023.1) and HR<jats:sub>adj<\/jats:sub>\u00a0=\u00a03.83 (CI, 1.20\u201012.3), respectively.<\/jats:p><jats:p>Beyond confirming the well\u2010known association between AIDs and B\u2010NHL, we found that AID is an adverse prognostic factor in B\u2010cell lymphoma, associated with a shortened time to relapse, suggesting that there are specific therapeutic challenges in the subgroup of patients suffering from both these diseases. Further work is required to address mechanisms of resistance to standard treatment in the setting of AID\u2010associated B\u2010NHL. In the era of immunotherapy, these findings have particular relevance.<\/jats:p>","DOI":"10.1002\/hon.2498","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T19:36:07Z","timestamp":1519414567000},"page":"457-462","source":"Crossref","is-referenced-by-count":18,"title":["Presence of autoimmune disease affects not only risk but also survival in patients with B\u2010cell non\u2010Hodgkin lymphoma"],"prefix":"10.1002","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6148-0421","authenticated-orcid":false,"given":"Geffen","family":"Kleinstern","sequence":"first","affiliation":[{"name":"School of Public Health Hadassah\u2010Hebrew University Medical Center  Jerusalem Israel"},{"name":"Department of Health Sciences Research Mayo Clinic  Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mor","family":"Averbuch","sequence":"additional","affiliation":[{"name":"School of Public Health Hadassah\u2010Hebrew University Medical Center  Jerusalem Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4625-9742","authenticated-orcid":false,"given":"Rania","family":"Abu Seir","sequence":"additional","affiliation":[{"name":"Department of Hematology Hadassah\u2010Hebrew University Medical Center  Jerusalem Israel"},{"name":"Department of Medical Laboratory Sciences Al Quds University  Abu Deis Jerusalem"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riki","family":"Perlman","sequence":"additional","affiliation":[{"name":"Department of Hematology Hadassah\u2010Hebrew University Medical Center  Jerusalem Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Ben Yehuda","sequence":"additional","affiliation":[{"name":"Department of Hematology Hadassah\u2010Hebrew University Medical Center  Jerusalem Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8324-3873","authenticated-orcid":false,"given":"Ora","family":"Paltiel","sequence":"additional","affiliation":[{"name":"School of Public Health Hadassah\u2010Hebrew University Medical Center  Jerusalem Israel"},{"name":"Department of Hematology Hadassah\u2010Hebrew University Medical Center  Jerusalem Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,2,22]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90242-6"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018472213872"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390625"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.20.2337"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24287"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu365"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgu013"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgu010"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgu011"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.2243"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709109157"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-011-0022-x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27944"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404782"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171709"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu290"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158360"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3337"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2498","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:15:47Z","timestamp":1695572147000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,22]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1002\/hon.2498"],"URL":"https:\/\/doi.org\/10.1002\/hon.2498","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,22]]}}}